Abstract:Cancer cells depend on coordinated changes in metabolism and epigenetic regulation to sustain growth, divide under stress, and adapt to therapy.

LET’S GET TECHNICAL. Scientists from the biotech company Life Biosciences are investigating the safety and potential side ...

Supergiant deep-sea isopods endure years without food by pairing an enlarged stomach with cold-adapted metabolic control.

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Cancer cells are quick to develop resistance to anti-tumor drugs. New research by scientists from the University of ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.

Modern glaucoma treatments can only preserve a patient’s current level of vision, offering no hope of restoration. A new Phase 1 clinical trial is using gene therapy that could turn back the clock on ...

Combined company to operate as Remix Therapeutics and advance Remix’s pipeline of novel small molecule therapies designed to reprogram RNA ...

A Boston company treated its first patient with a therapy intended to allow aging optic nerve cells to behave as though they were young again. The experimental treatment by Life Biosciences will ...

A Boston biotech company has administered what researchers are describing as the first human dose of a cellular rejuvenation drug, a milestone in the effort to treat age-related disease at the ...

Proprietary Synthetic Polynucleotide Platform Accelerates Non-Viral, Footprint-Free Induced Pluripotent Stem Cell Generation Amid Surging Commercialization of iPSC Therapies in Japan SEATTLE, June 16, ...